Interstitial lung disease associated with immune-checkpoint inhibitors in malignant diseases

被引：0
|
作者：
Yamagata, A. [1 ]
Yokoyama, T. [1 ]
Fukuda, Y. [1 ]
Ishida, T. [1 ]
机构：
[1] Kurashiki Cent Hosp, Dept Resp Med, Kurashiki, Okayama, Japan
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1307P
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Tumour burden and efficacy of immune-checkpoint inhibitors
    Filippo G. Dall’Olio
    Aurélien Marabelle
    Caroline Caramella
    Camilo Garcia
    Mihaela Aldea
    Nathalie Chaput
    Caroline Robert
    Benjamin Besse
    Nature Reviews Clinical Oncology, 2022, 19 : 75 - 90
  • [32] Current evidence and future perspectives of immune-checkpoint inhibitors in unresectable malignant pleural mesothelioma
    Hotta, Katsuyuki
    Fujimoto, Nobukazu
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [33] Hyperglycemic crisis associated with immune-checkpoint inhibitors therapy: Report of three cases
    Vera-Gomez, Pablo Rodriguez de
    Jimenez-Varo, Ignacio
    Martinez-Brocca, Maria Asuncion
    MEDICINA CLINICA, 2023, 160 (06): : 279 - 280
  • [34] Evading immune escape: synergy of COX and immune-checkpoint inhibitors
    Lisa Hutchinson
    Nature Reviews Clinical Oncology, 2015, 12 : 622 - 622
  • [35] Myocarditis associated with immune-checkpoint inhibitors diagnosed by cardiac magnetic resonance imaging
    Masafumi Fukumitsu
    Ryo Ariyasu
    Mitsutomi Ishiyama
    Toshiaki Mochizuki
    Koichi Takeda
    Makiko Ono
    Takuya Oyakawa
    Aya Ebihara
    Aya Nishizawa
    Junichi Tomomatsu
    Takahiro Kogawa
    Shigehisa Kitano
    Taro Shiga
    International Cancer Conference Journal, 2023, 12 : 109 - 114
  • [36] Myocarditis associated with immune-checkpoint inhibitors diagnosed by cardiac magnetic resonance imaging
    Fukumitsu, Masafumi
    Ariyasu, Ryo
    Ishiyama, Mitsutomi
    Mochizuki, Toshiaki
    Takeda, Koichi
    Ono, Makiko
    Oyakawa, Takuya
    Ebihara, Aya
    Nishizawa, Aya
    Tomomatsu, Junichi
    Kogawa, Takahiro
    Kitano, Shigehisa
    Shiga, Taro
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2023, 12 (02) : 109 - 114
  • [37] Evading immune escape: synergy of COX and immune-checkpoint inhibitors
    Hutchinson, Lisa
    NATURE REVIEWS CLINICAL ONCOLOGY, 2015, 12 (11) : 622 - 622
  • [38] Immune-related cutaneous adverse events associated with immune-checkpoint inhibitors: Our experience
    Pinilla-Martin, Belen
    Sanchez-Velazquez, Alba
    Vico-Alonso, Cristina
    Aragon-Miguel, Raquel
    Calleja-Algarra, Alba
    Jose Andres-Lencina, Juan
    Burillo-Martinez, Sara
    Tous-Romero, Fatima
    Maronas-Jimenez, Lidia
    Luis Ortiz-Romero, Pablo
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB223 - AB223
  • [39] Immune-related adverse events associated with immune-checkpoint inhibitors: A single center experience
    Samanci, N. S.
    Oruc, K.
    Bedir, S.
    Celik, E.
    Degerli, E.
    Derin, S.
    Demirelli, F. H.
    Ozguroglu, M.
    ANNALS OF ONCOLOGY, 2019, 30
  • [40] Are immune checkpoint inhibitors safe and effective in lung cancer patients with pre-existing interstitial lung disease?
    Zhu, Lin
    Gao, Rong
    Li, Han
    Zheng, Yahui
    Yang, Junling
    IMMUNOTHERAPY, 2024, 16 (07) : 465 - 480
12345